alexa Effect Of High-dose Methotrexate Chemotherapy On Intestinal Flora And Mucosal Barrier In Children With Acute Lymphoblastic Leukemia
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd World Congress on Cancer Science & Therapy
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Yong Kun Huang, Ye Meng, Wu Yang,Ying Zhang, Mei Liu, Jun Zhang and Qin Yao
Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956.S1.030
Abstract
Background:High-dose methotrexate (HDMTX) chemotherapy is generally accepted as an effective method for the treatment and prevention of extramedullary leukemia in children. However, it is unknown whether they are the damaged effects of HDMTX chemotherapy on intestinal mucosal barrier, which may in turn influence the progress or prognosis of leukemia. The levels of diamine oxidase (DAO) and endotoxin were measured to be able to evaluate the damaged intestinal mucosal barrier. The aim of this study was to study the effects of high-dose methotrexate (HDMTX) treatment on intestinal mucosal barrier in children with acute lymphocytic leukemia (ALL). Objective: High-dose methotrexate (HDMTX) chemotherapy is generally accepted as an effective method for the treatment and prevention of extramedullary leukemia in children. However, it is unknown whether HDMTX chemotherapy kills intestinal bacteria and affects intestinal mucosal barrier on a large scale, thus causing dysbacteriosis and mucosal disfunction, which may in turn influence the progress or prognosis of leukemia. The aim of this study was to examine changes in intestinal flora and intestinal mucosal barrier in children with acute lymphoblastic leukemia (ALL) treated with HDMTX chemotherapy. Methods: Bacterial DNA in stool from 36 healthy children and 36 ALL children were extracted and tested at A260 with a spectrophotometer before and after HDMTX chemotherapy. The primers of Bifidobacteria , Lactobacillus and Escherichia coli were designed according to the 16SrRNA/DNA bacterial sequences. Bacteria were qualitatively and quantitatively confirmed by routine polymerase chain reaction (PCR) and fluorescent quantitative PCR, respectively. The blood samples were collected from 30 normal children and from 30 children with ALL after 1 h, 24 h, 44 h and 68 h of intravenous drip HDMTX. The levels of diamine oxidase (DAO) and endotoxin were measured by the spectrophotometer in the isolated plasma. Results: Our data showed that the total amount of bacterial DNA in the stools of children with ALL was decreased by 29.6% compared with healthy children. The total amount of flora in the stools of children with ALL on the third and seventh days after chemotherapy were 1496.5+577.1 and 1966.6+598.3 ng/mL, respectively, which was notably less than before chemotherapy (2436.3+768.6 ng/mL) and healthy children (3479.3?870.5 ng/mL). The amount of Bifidobacteria, Lactobacillus and E. coli in the intestinal tract in the ALL group after chemotherapy had an apparent change, which decreased most clearly on the third day, and partially recovered on the seventh day after chemotherapy. The measured levels of plasma endotoxin and DAO in ALL group were significantly higher than in normal control group, the difference was statistically significant (P<0.01). The level of plasma endotoxin and DAO after 24 h and 44 h were both higher than 1 h and 68 h IV drip HDMTX, and reach the peak after 24 h, the difference was statistically significant (P<0.01). Conclusions: The amount of bacterial DNA, Bifidobacteria, Lactobacillus and E. coli in the stools was in decrease significantly compared with the control group. The levels of plasma endotoxin and DAO in ALL group were apparently higher than in normal control group. Leukemia itself and HDMTX chemotherapy can all cause intestinal dysbacteriosis and intestinal mucosal barrier disfunction in children with ALL. Keywords: Acute lymphoblastic leukemia, high-dose methotrexate, intestinal flora, dysbacteriosis, mucosal barrier, and disfunction.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords